Canada is clearly leading the way on global cannabis reform; the question remains will the United States follow suit quickly enough to capitalize on this nascent market before Canada asserts its dominance as a global provider of quality hemp and marijuana products?
Category: Hemp and CBD
DEA Reschedules Epidiolex
The DEA has rescheduled Epidiolex, a product containing CBD derived from marijuana, from schedule 1 to schedule 5.
Buckle Up- What If The 2018 Farm Bill Is Not Enacted In September?
We can expect a bumpy ride until the 2018 Farm Bill is passed. So, buckle in and hold on for the next few months. Change is coming.
Ohio Board of Pharmacy Takes Aim at CBD
The Ohio Board of Pharmacy issued two Guidance Documents regarding CBD this week that have caused an uproar. Is the Pharmacy Board right?
Cannabis Intellectual Property- Do Your Products Violate A Patent?
I am not exaggerating when I say that the future of your cannabis business, and the industry at large, may depend on the outcome of this case.
Is the “Joint Statement of Principles on Industrial Hemp” still relevant? Was it ever?
Regardless of the way this document has been used, the Joint Statement is not a reliable document on policy or law.
Hemp and CBD: Is Red Yeast Rice the Proper Legal Precedent for FDA Regulation?
The next big battleground for CBD is the extent to which it will be regulated by the FDA.
California Goes Off the Rails In New FAQ About CBD
The California Department of Public Health (CDPH), Food and Drug Branch (FDB),…
Rod Quoted in Pot Network News Story About CBD Oil
In light of the FDA’s approval of Epidiolex, a marijuana based CBD…